PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 26, 2026Cellular and Molecular Neurobiology2 citationsOpen Access

D-serine: A Multitalented Neuromodulator in Brain Function, Systemic Homeostasis, and Disease

View Full Paper
JWJing WangHarbin University of Science and TechnologyYGYujin GuoJining First People's HospitalWHWenxiu Han

Key Points

  • This review assesses the multifaceted roles of D-serine in brain function and systemic health.
  • Summary of recent advances in D-serine research
  • Exploration of signaling pathways and regulation
  • Analysis of D-serine's role in CNS and peripheral disorders
  • Discussion on therapeutic strategies targeting D-serine pathways
  • D-serine is crucial for synaptic plasticity, learning, and memory
  • Disrupted homeostasis is linked to schizophrenia, Alzheimer's disease, and addiction
  • D-serine functions as a metabolic sensor and engages in non-canonical signaling
  • Potential therapeutic targets include D-amino acid oxidase inhibitors and gene therapy.

Abstract

D-serine is an endogenous D-amino acid and a crucial co-agonist for the N-methyl-D-aspartate (NMDA) receptor, well known as a key regulator of synaptic plasticity, learning, and memory. This review summarizes recent advances that extend beyond this canonical role, positioning D-serine as a dynamic nexus linking brain function to systemic homeostasis. We explore its spatiotemporal dynamics in synaptic microdomains, sophisticated epigenetic and transcriptional regulation, and emerging role as a metabolic sensor linking cellular energetics to neuronal signaling. Furthermore, we highlight novel non-canonical signaling pathways, including its function as a ligand for the glutamate delta-1 receptor (GluD1) and its direct role in peripheral organs like the gut and kidney. The pathophysiological implications of disrupted D-serine homeostasis are detailed across a spectrum of CNS disorders—from schizophrenia and Alzheimer’s disease (AD) to addiction and neuropathic pain—as well as in peripheral conditions including diabetic complications and osteoporosis. Finally, we discuss the translational potential of targeting D-serine pathways through innovative therapeutic strategies—such as serine racemase (SR) modulators, D-amino acid oxidase (DAAO) inhibitors, and gene therapy—and its promise as a biomarker for personalized medicine in neurology and psychiatry.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/699f956d1bc9fecf3dab32fchttps://doi.org/10.1007/s10571-026-01696-9
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1D-Serine inhibits non-ionotropic NMDA receptor signaling2024 · 1 citations
  2. 2Early involvement of D-serine in β-amyloid-dependent pathophysiology2025
  3. 3The Development of a Regulator of Human Serine Racemase for N-Methyl-D-aspartate Function2024 · 3 citations
  4. 4D-serine ameliorates cognitive deficits by preserving neuronal and synaptic function in experimental anti-NMDAR encephalitis2026 · 1 citations
  5. 5D-serine suppresses one-carbon metabolism by competing with mitochondrial L-serine transport2025